{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:47:34Z","timestamp":1791974854732,"version":"4.4.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82302093"],"award-info":[{"award-number":["82302093"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Domestic Research Program of Maternity and Child Healthcare Hospital","award":["FYA2022005"],"award-info":[{"award-number":["FYA2022005"]}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["2023A1515010151"],"award-info":[{"award-number":["2023A1515010151"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shenzhen Science and Technology Innovation Council Funded Project for Basic Research","award":["JCYJ20220530155201004"],"award-info":[{"award-number":["JCYJ20220530155201004"]}]},{"name":"Shenzhen Key Laboratory of Maternal and Child Health and Diseases","award":["ZDSYS20230626091559006"],"award-info":[{"award-number":["ZDSYS20230626091559006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>X-linked Alport syndrome (XLAS) caused by X-linked COL4A5 gene mutation is a hereditary disease that affects mainly the kidney. XLAS patients, especially males whose single copy of the COL4A5 gene is disrupted, suffer from a life-threatening renal disease, the mechanism of which remains unclear. Renal fibrosis is a characteristic pathology observed in XLAS kidney tissue. However, the molecular path from COL4A5 loss-of-function to fibrotic pathology is largely unknown. On the basis of a previously established XLAS mouse model, our study revealed an activated CD44-TGF\u03b2 signaling known to strongly promote fibrosis, along with an increased level of low molecular weight hyaluronan (LMW-HA) instead of high molecular weight hyaluronan (HMW-HA), to activate CD44-dependent TGF\u03b2 signaling in XLAS renal tissues. Additionally, hyaluronan synthase 2 (HAS2), an enzyme primarily responsible for HA production, was found to be upregulated in XLAS. In particular, in vitro studies revealed that COL4A5 knockdown in human kidney-derived HEK-293 cells can upregulate HAS2 at both the RNA and protein levels. The novel contribution of our study is finding that COL4A5 deficiency may lead to HAS2 overexpression and HA accumulation to activate CD44-TGF\u03b2 signaling, thereby promoting fibrosis, possibly suggesting that HAS2 and CD44 are potential therapeutic targets for impeding renal fibrosis in XLAS.<\/jats:p>","DOI":"10.1186\/s10020-025-01146-0","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T17:35:57Z","timestamp":1741800957000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Increased HA\/CD44\/TGF\u03b2 signaling implicates in renal fibrosis of a Col4a5 mutant Alport mice"],"prefix":"10.1186","volume":"31","author":[{"given":"Yantao","family":"Bao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuankai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jindi","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyuan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baojiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"1146_CR1","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1242\/jcs.021683","volume":"121","author":"PS Acharya","year":"2008","unstructured":"Acharya PS, Majumdar S, Jacob M, Hayden J, Mrass P, Weninger W, et al. Fibroblast migration is mediated by CD44-dependent TGF\u03b2 activation. J Cell Sci. 2008;121:1393\u2013402. https:\/\/doi.org\/10.1242\/jcs.021683","journal-title":"J Cell Sci"},{"key":"1146_CR2","doi-asserted-by":"publisher","unstructured":"Berdiaki A, Neagu M, Spyridaki I, Kuskov A, Perez S, Nikitovic D. Hyaluronan and reactive oxygen species signaling\u2014novel cues from the matrix?? Antioxidants. 2023;12. https:\/\/doi.org\/10.3390\/antiox12040824","DOI":"10.3390\/antiox12040824"},{"key":"1146_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s00395-017-0647-9","volume":"112","author":"S-H Chang","year":"2017","unstructured":"Chang S-H, Yeh Y-H, Lee J-L, Hsu Y-J, Kuo C-T, Wei-Jan Chen. Transforming growth factor-\u03b2-mediated CD44\/STAT3 signaling contributes to the development of atrial fibrosis and fibrillation. Basic Res Cardiol. 2017;112:58. https:\/\/doi.org\/10.1007\/s00395-017-0647-9","journal-title":"Basic Res Cardiol"},{"key":"1146_CR4","doi-asserted-by":"publisher","unstructured":"Escasany E, Lanz\u00f3n B et al. Almudena Garc\u00eda-Carrasco, Adriana Izquierdo-Lahuerta, Luc\u00eda Torres, Patricia Corrales. Transforming growth factor \u03b23 deficiency promotes defective lipid metabolism and fibrosis in murine kidney. Disease Models & Mechanisms. 2021;14:dmm048249. https:\/\/doi.org\/10.1242\/dmm.048249","DOI":"10.1242\/dmm.048249"},{"key":"1146_CR5","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.kint.2017.09.020","volume":"93","author":"J Eymael","year":"2018","unstructured":"Eymael J, Sharma S, Loeven MA, Jack F, Wetzels F, Mooren S, Florquin, et al. CD44 is required for the pathogenesis of experimental crescentic glomerulonephritis and collapsing focal segmental glomerulosclerosis. Kidney Int. 2018;93:626\u201342. https:\/\/doi.org\/10.1016\/j.kint.2017.09.020","journal-title":"Kidney Int"},{"key":"1146_CR6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41581-024-00907-0","volume":"21","author":"AB Fogo","year":"2025","unstructured":"Fogo AB, Harris RC. Crosstalk between glomeruli and tubules. Nat Rev Nephrol. 2025;21:189\u201399. https:\/\/doi.org\/10.1038\/s41581-024-00907-0","journal-title":"Nat Rev Nephrol"},{"key":"1146_CR7","doi-asserted-by":"publisher","unstructured":"Gomes AM, Lopes D, Almeida C, Santos S, Malheiro J, Lousa I, et al. Potential renal damage biomarkers in Alport syndrome\u2014a review of the literature. Int J Mol Sci. 2022;23. https:\/\/doi.org\/10.3390\/ijms23137276","DOI":"10.3390\/ijms23137276"},{"key":"1146_CR8","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1046\/j.1523-1755.2003.00779.x","volume":"63","author":"O Gross","year":"2003","unstructured":"Gross O, Beirowski B, Koepke M-L, Kuck J, Reiner M, Addicks K, et al. Preemptive Ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome. Kidney Int. 2003;63:438\u201346. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00779.x","journal-title":"Kidney Int"},{"key":"1146_CR9","unstructured":"Kashtan CE, Alport Syndrome. 2001 Aug 28 [Updated 2019 Feb 21]. In: Adam MP, Feldman J, Mirzaa GM, editors. GeneReviews\u00ae. Seattle (WA): University of Washington, Seattle; 1993\u20132025. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1207\/"},{"key":"1146_CR10","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00467-021-05113-9","volume":"37","author":"A Kaul","year":"2022","unstructured":"Kaul A, Singampalli KL, Umang M, Parikh L, Yu SG, Keswani, Wang X. Hyaluronan, a double-edged sword in kidney diseases. Pediatr Nephrol. 2022;37:735\u201344. https:\/\/doi.org\/10.1007\/s00467-021-05113-9","journal-title":"Pediatr Nephrol"},{"key":"1146_CR11","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nrneph.2012.259","volume":"9","author":"J Kruegel","year":"2013","unstructured":"Kruegel J, Rubel D, Gross O. Alport syndrome\u2014insights from basic and clinical research. Nat Rev Nephrol. 2013;9:170\u201378. https:\/\/doi.org\/10.1038\/nrneph.2012.259","journal-title":"Nat Rev Nephrol"},{"key":"1146_CR12","doi-asserted-by":"publisher","unstructured":"Liu M, Tolg C, Turley E. Dissecting the dual nature of hyaluronan in the tumor microenvironment. Front Immunol. 2019;10. https:\/\/doi.org\/10.3389\/fimmu.2019.00947","DOI":"10.3389\/fimmu.2019.00947"},{"key":"1146_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1089\/wound.2020.1192","volume":"10","author":"PJ McKeown-Longo","year":"2021","unstructured":"McKeown-Longo PJ, Paul JH. Hyaluronan, transforming growth factor \u0392, and extra domain A-fibronectin: a fibrotic triad. Adv Wound Care. 2021;10:137\u201352.","journal-title":"Adv Wound Care"},{"key":"1146_CR14","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","volume":"12","author":"Xiao-ming Meng","year":"2016","unstructured":"Meng Xiao-ming, Nikolic-Paterson DJ, Hui, Yao Lan. TGF-\u03b2: the master regulator of fibrosis. Nat Rev Nephrol. 2016;12:325\u201338. https:\/\/doi.org\/10.1038\/nrneph.2016.48","journal-title":"Nat Rev Nephrol"},{"key":"1146_CR15","doi-asserted-by":"publisher","first-page":"eaao1822","DOI":"10.1126\/scisignal.aao1822","volume":"10","author":"AC Midgley","year":"2017","unstructured":"Midgley AC, Oltean S, Hascall V, Woods EL, Steadman R, Phillips, and Soma Meran. Nuclear hyaluronidase 2 drives alternative splicing of CD44 pre-mRNA to determine profibrotic or antifibrotic cell phenotype. Sci Signal. 2017;10:eaao1822. https:\/\/doi.org\/10.1126\/scisignal.aao1822","journal-title":"Sci Signal"},{"key":"1146_CR16","doi-asserted-by":"publisher","unstructured":"Rabelink TJ, Wang G, Johan, van der Vlag, van den Berg BM. The roles of hyaluronan in kidney development, physiology and disease. Nature Reviews Nephrology. 2024;20:822\u201332. https:\/\/doi.org\/10.1038\/s41581-024-00883-5","DOI":"10.1038\/s41581-024-00883-5"},{"key":"1146_CR18","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1681\/ASN.2005080879","volume":"17","author":"W Selbi","year":"2006","unstructured":"Selbi W, Day AJ, Rugg MS, F\u00fcl\u00f6p C, Carol A, Bowen T, et al. Overexpression of hyaluronan synthase 2 alters hyaluronan distribution and function in proximal tubular epithelial cells. J Am Soc Nephrol. 2006;17:1553\u201367. https:\/\/doi.org\/10.1681\/ASN.2005080879","journal-title":"J Am Soc Nephrol"},{"key":"1146_CR19","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/glycob\/cwaa118","volume":"31","author":"R \u0160\u00ednov\u00e1","year":"2021","unstructured":"\u0160\u00ednov\u00e1 R, \u017d\u00e1dn\u00edkov\u00e1 P, \u0160afr\u00e1nkov\u00e1 B, Ne\u0161porov\u00e1 K. Anti-HA antibody does not detect hyaluronan. Glycobiology. 2021;31:520\u201323. https:\/\/doi.org\/10.1093\/glycob\/cwaa118","journal-title":"Glycobiology"},{"key":"1146_CR20","doi-asserted-by":"publisher","unstructured":"\u0160olt\u00e9s L, Mendichi R, Kogan G, Schiller J, Stankovsk\u00e1 M. and J. Arnhold. Degradative action of reactive oxygen species on hyaluronan. Biomacromolecules. 2006;7:659\u201368. https:\/\/doi.org\/10.1021\/bm050867v","DOI":"10.1021\/bm050867v"},{"key":"1146_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-76068-4","volume":"10","author":"J Song","year":"2020","unstructured":"Song J, Ying N, Saga K, Kawanishi K, Hashikami, Michiyasu Takeyama, and Michio Nagata. Bidirectional, non-necrotizing glomerular crescents are the critical pathology in X-linked Alport syndrome mouse model harboring nonsense mutation of human COL4A5. Sci Rep. 2020;10:1\u201313. https:\/\/doi.org\/10.1038\/s41598-020-76068-4","journal-title":"Sci Rep"},{"key":"1146_CR22","doi-asserted-by":"publisher","unstructured":"Suh SH, Hong S, Choi CS, Kim et al. In J. Kim, Seong K. Ma, James W. Scholey,. Olmesartan attenuates kidney fibrosis in a murine model of Alport syndrome by suppressing tubular expression of TGF\u03b2. Int J Mol Sci. 2019;20. https:\/\/doi.org\/10.3390\/ijms20153843","DOI":"10.3390\/ijms20153843"},{"key":"1146_CR24","doi-asserted-by":"publisher","first-page":"eabe0407","DOI":"10.1126\/scitranslmed.abe0407","volume":"13","author":"T Sun","year":"2021","unstructured":"Sun T, Huang Z, Liang W-C, Yin J, Lin WY, Wu J, et al. TGF\u03b22 and TGF\u03b23 isoforms drive fibrotic disease pathogenesis. Sci Transl Med. 2021;13:eabe0407. https:\/\/doi.org\/10.1126\/scitranslmed.abe0407","journal-title":"Sci Transl Med"},{"key":"1146_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2024.02.021","volume":"368","author":"J Sun","year":"2024","unstructured":"Sun J, Zhao X, Shen H, Dong J, Rong S, Cai W, Zhang R. CD44-targeted melanin-based nanoplatform for alleviation of ischemia\/reperfusion-induced acute kidney injury. J Controlled Release. 2024;368:1\u201314. https:\/\/doi.org\/10.1016\/j.jconrel.2024.02.021","journal-title":"J Controlled Release"},{"key":"1146_CR25","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1186\/1471-2105-7-520","volume":"7","author":"J-P Vert","year":"2006","unstructured":"Vert J-P, Foveau N, Lajaunie C, Vandenbrouck Y. An accurate and interpretable model for SiRNA efficacy prediction. BMC Bioinformatics. 2006;7:520. https:\/\/doi.org\/10.1186\/1471-2105-7-520","journal-title":"BMC Bioinformatics"},{"key":"1146_CR26","doi-asserted-by":"publisher","unstructured":"Warady BA, Agarwal R, Bangalore S, Chapman A, Levin A, Stenvinkel P et al. Alport syndrome classification and management. Kidney Medicine. 2020;2:639\u201349. https:\/\/doi.org\/10.1016\/j.xkme.2020.05.014","DOI":"10.1016\/j.xkme.2020.05.014"},{"key":"1146_CR27","doi-asserted-by":"publisher","first-page":"108594","DOI":"10.1016\/j.exer.2021.108594","volume":"207","author":"SE Wilson","year":"2021","unstructured":"Wilson SE. TGF beta\u2013\u20091,\u20132 and\u2013\u20093 in the modulation of fibrosis in the cornea and other organs. Exp Eye Res. 2021;207:108594. https:\/\/doi.org\/10.1016\/j.exer.2021.108594","journal-title":"Exp Eye Res"},{"key":"1146_CR28","doi-asserted-by":"publisher","unstructured":"Wu Wei-qing, Zhang Jia-xun, Cui Ying-xia, Zhang Ming-chao, Chen Xiao-hang, Duan S, et al. A mouse model for X-linked Alport syndrome induced by Del-ATGG in the Col4a5 gene. Front Med. 2023;10. https:\/\/doi.org\/10.3389\/fmed.2023.1086756","DOI":"10.3389\/fmed.2023.1086756"},{"key":"1146_CR29","doi-asserted-by":"publisher","first-page":"L926","DOI":"10.1152\/ajplung.00456.2020","volume":"320","author":"H Xia","year":"2021","unstructured":"Xia H, Herrera J, Smith K, Yang L, Gilbertsen A, Benyumov A, et al. Hyaluronan\/CD44 axis regulates S100A4-mediated mesenchymal progenitor cell fibrogenicity in idiopathic pulmonary fibrosis. Am J Physiology-Lung Cell Mol Physiol. 2021;320:L926\u201341. https:\/\/doi.org\/10.1152\/ajplung.00456.2020","journal-title":"Am J Physiology-Lung Cell Mol Physiol"},{"key":"1146_CR30","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.ekir.2017.04.011","volume":"2","author":"T Yamamura","year":"2017","unstructured":"Yamamura T, Nozu K, Fu XJ, Nozu Y, Ye MJ, Shono A, et al. Natural history and genotype\u2013phenotype correlation in female X-linked Alport syndrome. Kidney Int Rep. 2017;2:850\u201355. https:\/\/doi.org\/10.1016\/j.ekir.2017.04.011","journal-title":"Kidney Int Rep"},{"key":"1146_CR31","doi-asserted-by":"publisher","first-page":"eaat9284","DOI":"10.1126\/scitranslmed.aat9284","volume":"11","author":"Y Yang","year":"2019","unstructured":"Yang Y, Mee M, Noureddin C, Liu K, Ohashi SY, Kim D, Ramnath, et al. Hyaluronan synthase 2\u2013mediated hyaluronan production mediates Notch1 activation and liver fibrosis. Sci Transl Med. 2019;11:eaat9284. https:\/\/doi.org\/10.1126\/scitranslmed.aat9284","journal-title":"Sci Transl Med"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01146-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-025-01146-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01146-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T17:36:07Z","timestamp":1741800967000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-025-01146-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1146"],"URL":"https:\/\/doi.org\/10.1186\/s10020-025-01146-0","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]},"assertion":[{"value":"21 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experiments were approved by the Animal Ethics Committees of Shenzhen Maternity and Child Healthcare Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"96"}}